Drug Side Effects
Search
CUTANEOUS SPOROTRICHOSIS
CUTANEOUS SPOROTRICHOSIS
was reported 48 times
CUTANEOUS SPOROTRICHOSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Allylamine Antifungal [EPC]
3
0.0004
1
Tetracycline-class Antibacterial [EPC]
3
0.0004
2
Lipid-based Polyene Antifungal [EPC]
4
0.0003
3
Antimetabolite Immunosuppressant [EPC]
4
0.0002
4
RNA Synthetase Inhibitor Antibacterial [EPC]
2
0.0001
5
Human Immunoglobulin G [EPC]
3
0.0001
6
Oxazolidinone Antibacterial [EPC]
4
0.0001
7
Polyene Antifungal [EPC]
4
0.0001
8
Interleukin-12 Antagonist [EPC]
8
0.0001
9
Interleukin-23 Antagonist [EPC]
8
0.0001
10
Azole Antifungal [EPC]
12
0.0001
11
Tetracycline-class Drug [EPC]
4
0.0001
12
Calcineurin Inhibitor Immunosuppressant [EPC]
6
0.0000
13
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
3
0.0000
14
Purine Antimetabolite [EPC]
3
0.0000
15
Folate Analog Metabolic Inhibitor [EPC]
10
0.0000
16
Corticosteroid [EPC]
26
0.0000
17
Macrolide Antimicrobial [EPC]
1
0.0000
18
Selective T Cell Costimulation Modulator [EPC]
2
0.0000
19
Sulfonylurea [EPC]
1
0.0000
20
Phosphodiesterase 5 Inhibitor [EPC]
1
0.0000
21
Angiotensin Converting Enzyme Inhibitor [EPC]
1
0.0000
22
CD20-directed Cytolytic Antibody [EPC]
2
0.0000
23
Tumor Necrosis Factor Blocker [EPC]
6
0.0000
24
Kinase Inhibitor [EPC]
3
0.0000